Location History:
- Pacifica, CA (US) (2003)
- Burlingame, CA (US) (2004)
Company Filing History:
Years Active: 2003-2004
Title: The Innovations of Kimberly Carr Ferguson
Introduction
Kimberly Carr Ferguson is a notable inventor based in Burlingame, CA (US). She has made significant contributions to the field of lipid metabolism through her innovative research and patented inventions. With a total of 2 patents, her work has implications for both pharmaceutical and agricultural industries.
Latest Patents
Ferguson's latest patents focus on animal models and methods for analyzing lipid metabolism. These models are genetically modified to express or mis-express proteins involved in the sterol regulatory element binding protein (SREBP) pathway. The genetically modified animal models exhibit identifiable phenotypes, making them useful in assays for studying lipid metabolism and compounds that can modulate these pathways. Additionally, her patents describe methods for studying lipid metabolism in living nematodes using fluorescently-labelled fatty acid conjugates, such as BODITY™ fatty acid conjugates. Furthermore, her inventions include novel nucleic acid and protein sequences related to the SREBP pathway, as well as methods for identifying and producing insulin-like proteins.
Career Highlights
Ferguson is currently associated with Exelixis, Inc., where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of lipid metabolism and its implications for health and disease.
Collaborations
Some of her notable coworkers include Stephen Kohl Doberstein and Sheila Akiko Homburger, who have collaborated with her on various projects related to her research.
Conclusion
Kimberly Carr Ferguson's innovative work in lipid metabolism and her patented inventions highlight her significant contributions to science and medicine. Her research continues to pave the way for advancements in understanding metabolic pathways and their applications.